ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

EGLE Eagle Bulk Shipping Inc

62.60
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Eagle Bulk Shipping Inc NYSE:EGLE NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 62.60 0 01:00:00

Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law Firm

03/01/2024 7:57pm

PR Newswire (US)


Eagle Bulk Shipping (NYSE:EGLE)
Historical Stock Chart


From Nov 2023 to May 2024

Click Here for more Eagle Bulk Shipping Charts.

NEW YORK, Jan. 3, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. 

Kuehn Law, PLLC (PRNewsfoto/Kuehn Law, PLLC)

Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: 

  • Eagle Bulk Shipping Inc. (NYSE: EGLE)

Per the merger agreement, Eagle Bulk shareholders will get 2.6211 Star Bulk shares for each Eagle share, valuing each Eagle share at about $52.60. Post-merger, Star Bulk and Eagle shareholders will own roughly 71% and 29% of the merged company, respectively.

  • Icosavax, Inc. (Nasdaq: ICVX)

According to the agreement terms, AstraZeneca will, via a subsidiary, start a tender offer to purchase all outstanding shares of Icosavax for $15.00 per share in cash. Additionally, shareholders will receive a non-tradable contingent value right for up to $5.00 in cash.

  • Rain Oncology, Inc. (Nasdaq: RAIN)

Under the merger agreement, Pathos will buy Rain Oncology at $1.16 per share in cash, plus a non-tradeable CVR for potential extra cash payments up to $0.17 per share.

  • Alteryx, Inc. (NYSE: AYX)

Under the proposed transaction, Clearlake Capital Group and Insight Partners will acquire Alteryx for $48.25 in cash for each share of Class A or Class B common stock.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

How to Get Involved:

Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients.  Shareholders are advised to act promptly, as legal rights may be time-sensitive.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-egle-icvx-rain-and-ayx-investors-to-contact-law-firm-302025655.html

SOURCE Kuehn Law, PLLC

Copyright 2024 PR Newswire

1 Year Eagle Bulk Shipping Chart

1 Year Eagle Bulk Shipping Chart

1 Month Eagle Bulk Shipping Chart

1 Month Eagle Bulk Shipping Chart

Your Recent History

Delayed Upgrade Clock